A 2022 New England Journal of Medicine article co-authored by The Bliss Group’s Managing Partner Michael Roth and Colin Foster, President of The Next Practice, details a clinical trial sponsored by Johns Hopkins University on the use of convalescent blood plasma prophylactic or treatment for COVID-19 in its early stages. The
what's next
What We Do
The future is shaped by the decisions we make every day. Our mission is to lead the way forward and create the next model or idea or campaign that will make a difference in the lives of our clients and the audiences they serve.
The Bliss Group is a data-driven marketing communications agency that specializes in building value for our clients across the healthcare, financial, business and professional services sectors. We are storytellers and integrated marketers working with data scientists to create proprietary algorithms and innovative media models that give our clients a unique market advantage.
Our Team
Bob Pearson
CEO
Cortney Stapleton
Managing Partner
Michael Roth
Managing Partner
We’re proud to be geeks. We love navigating regulated industries, addressing complex problems, creating proprietary analytics tools and researching what’s next. Your problems and opportunities fuel our workflow.
How We Think
We love to share what we are learning with you, whether it is writing a blog post, moderating a panel or creating a video or podcast. The more we share, the more we all learn together.